DRI, DIEGO ALEJANDRO
DRI, DIEGO ALEJANDRO
DIPARTIMENTO DI CHIMICA E TECNOLOGIE DEL FARMACO
Clinical Trials and Machine Learning: Regulatory Approach Review
2021 Dri, Diego Alejandro; Massella, Maurizio; Gramaglia, Donatella; Marianecci, Carlotta; Petraglia, Sandra
Critical Analysis and Quality Assessment of Nanomedicines and Nanocarriers in Clinical Trials: Three Years of Activity at the Clinical Trials Office
2022 Dri, DIEGO ALEJANDRO; Gaucci, Elisa; Torrieri, Ilaria; Carafa, Maria; Marianecci, Carlotta; Gramaglia, Donatella
Design and synthesis of a new furanosic sialylmimetic as a potential influenza neuraminidase viral inhibitor
2005 Bianco, Armandodoriano; Brufani, Mario; Dri, D. A.; Melchioni, C.; Filocamo, Luigi
Nanomedicines and nanocarriers in clinical trials: surfing through regulatory requirements and physico-chemical critical quality attributes
2023 Dri, Diego Alejandro; Rinaldi, Federica; Carafa, Maria; Marianecci, Carlotta
Quality Assessment of Investigational Medicinal Products in COVID-19 Clinical Trials: One Year of Activity at the Clinical Trials Office
2021 Dri, Diego Alejandro; Praticò, Giulia; Gaucci, Elisa; Marianecci, Carlotta; Gramaglia, Donatella
Surfactants, nanomedicines and nanocarriers: a critical evaluation on clinical trials
2021 Dri, D. A.; Marianecci, C.; Carafa, M.; Gaucci, E.; Gramaglia, D.
The preparation of an ionic liquid containing a cyano group and its properties as a lithium battery electrolyte
2004 Egashira, M.; Okada, S.; Yamaki, J. I.; Dri, D. A.; Bonadies, Francesco; Scrosati, Bruno
The Preparation of quaternary ammoniun-based ionic liquid containing cyano group and its properties in a lithium battery electrolyte
2004 Egashira, M.; Okada, Shigeto; Yamaki, J.; Dri, D. A.; Bonadies, Francesco